Cargando…
Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial
BACKGROUND: For children requiring split-thickness skin grafting for burn injury, the optimum donor site dressing is an ongoing subject of debate. The most common dressings in use, both regionally and worldwide, are calcium alginates. We will compare an alginate with two other dressings, all of whic...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335760/ https://www.ncbi.nlm.nih.gov/pubmed/25887128 http://dx.doi.org/10.1186/s13063-015-0557-9 |
_version_ | 1782358392346509312 |
---|---|
author | McBride, Craig A Kimble, Roy M Stockton, Kellie |
author_facet | McBride, Craig A Kimble, Roy M Stockton, Kellie |
author_sort | McBride, Craig A |
collection | PubMed |
description | BACKGROUND: For children requiring split-thickness skin grafting for burn injury, the optimum donor site dressing is an ongoing subject of debate. The most common dressings in use, both regionally and worldwide, are calcium alginates. We will compare an alginate with two other dressings, all of which are in current use in the Pegg Leditschke Paediatric Burns Centre (PLPBC), to determine which dressing performs the best. METHODS/DESIGN: This is a randomised, prospective single center parallel three-arm trial comparing three donor site wound (DSW) dressings: Algisite™ M, a calcium alginate dressing; Cuticerin™, a smooth acetate gauze impregnated with water-repellent ointment (petrolatum, paraffin and Eucerite®) and Sorbact®, a gauze mesh coated with a dialkylcarbamoyl chloride (DACC) and amorphous hydrogel. Primary outcomes are days to complete DSW healing, and pain. Previously validated measures will be used for all outcomes. Secondary outcomes are: itch; scar appearance at three, six and 12 months; ease of dressing application and removal and dressing costs and utility. Results will be analysed on an intention-to-treat basis. Donor site thickness will be measured with a small biopsy from the center of the graft, to document the depth of the DSW across the groups. DISCUSSION: This study will provide comprehensive short- and long-term data on DSW dressings in pediatric split-thickness skin grafting. The best-performing dressing will become the preferred dressing for the PLPBC. We will provide rigorous data against which other dressings can be compared in future, recognising that alginates are the most common DSW dressing currently in use. Our study design replicates a real-world scenario in order to identify clinically significant differences between the three dressings. TRIAL REGISTRATION: This trial was prospectively registered on 8 April 2014 with the Australia and New Zealand Clinical Trials Register (identifier: ACTRN12614000380695). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-015-0557-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4335760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43357602015-02-21 Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial McBride, Craig A Kimble, Roy M Stockton, Kellie Trials Study Protocol BACKGROUND: For children requiring split-thickness skin grafting for burn injury, the optimum donor site dressing is an ongoing subject of debate. The most common dressings in use, both regionally and worldwide, are calcium alginates. We will compare an alginate with two other dressings, all of which are in current use in the Pegg Leditschke Paediatric Burns Centre (PLPBC), to determine which dressing performs the best. METHODS/DESIGN: This is a randomised, prospective single center parallel three-arm trial comparing three donor site wound (DSW) dressings: Algisite™ M, a calcium alginate dressing; Cuticerin™, a smooth acetate gauze impregnated with water-repellent ointment (petrolatum, paraffin and Eucerite®) and Sorbact®, a gauze mesh coated with a dialkylcarbamoyl chloride (DACC) and amorphous hydrogel. Primary outcomes are days to complete DSW healing, and pain. Previously validated measures will be used for all outcomes. Secondary outcomes are: itch; scar appearance at three, six and 12 months; ease of dressing application and removal and dressing costs and utility. Results will be analysed on an intention-to-treat basis. Donor site thickness will be measured with a small biopsy from the center of the graft, to document the depth of the DSW across the groups. DISCUSSION: This study will provide comprehensive short- and long-term data on DSW dressings in pediatric split-thickness skin grafting. The best-performing dressing will become the preferred dressing for the PLPBC. We will provide rigorous data against which other dressings can be compared in future, recognising that alginates are the most common DSW dressing currently in use. Our study design replicates a real-world scenario in order to identify clinically significant differences between the three dressings. TRIAL REGISTRATION: This trial was prospectively registered on 8 April 2014 with the Australia and New Zealand Clinical Trials Register (identifier: ACTRN12614000380695). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-015-0557-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-08 /pmc/articles/PMC4335760/ /pubmed/25887128 http://dx.doi.org/10.1186/s13063-015-0557-9 Text en © McBride et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol McBride, Craig A Kimble, Roy M Stockton, Kellie Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial |
title | Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial |
title_full | Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial |
title_fullStr | Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial |
title_full_unstemmed | Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial |
title_short | Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial |
title_sort | three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335760/ https://www.ncbi.nlm.nih.gov/pubmed/25887128 http://dx.doi.org/10.1186/s13063-015-0557-9 |
work_keys_str_mv | AT mcbridecraiga threedonorsitedressingsinpediatricsplitthicknessskingraftsstudyprotocolforarandomisedcontrolledtrial AT kimbleroym threedonorsitedressingsinpediatricsplitthicknessskingraftsstudyprotocolforarandomisedcontrolledtrial AT stocktonkellie threedonorsitedressingsinpediatricsplitthicknessskingraftsstudyprotocolforarandomisedcontrolledtrial |